Ampio Pharmaceuticals Inc
General ticker "AMPE" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $2.9K
Ampio Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -38.6%.
Estimated limits based on current volatility of 36.8%: low 0.00$, high 0.00$
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.10$, 3.83$]
- 2024-12-30 to 2025-12-30 estimated range: [0.97$, 3.10$]
Financial Metrics affecting the AMPE estimates:
- Negative: Non-GAAP EPS, $ of -11.01 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -82.49 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
Short-term AMPE quotes
Long-term AMPE plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $3.50MM | $5.98MM | $0.00MM |
| Operating Expenses | $20.57MM | $22.32MM | $9.52MM |
| Operating Income | $-17.07MM | $-16.34MM | $-9.52MM |
| Non-Operating Income | $0.00MM | $0.00MM | $0.89MM |
| R&D Expense | $11.90MM | $8.92MM | $2.44MM |
| Income(Loss) | $-17.07MM | $-16.34MM | $-8.63MM |
| Profit(Loss) | $-17.07MM | $-16.34MM | $-8.63MM |
| Stockholders Equity | $27.28MM | $11.79MM | $3.36MM |
| Inventory | $1.19MM | $0.00MM | $0.00MM |
| Assets | $38.83MM | $13.59MM | $5.74MM |
| Operating Cash Flow | $-14.09MM | $-21.13MM | $-8.56MM |
| Capital expenditure | $0.10MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.10MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $30.73MM | $-0.11MM | $0.00MM |
| Earnings Per Share* | $-18.79 | $-11.24 | $-10.67 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.